What does CUSIP 14757U109 represent in this 13F holders report?

CUSIP 14757U109 is the security identifier for CASI - CASI PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held CASI - CASI PHARMACEUTICALS INC - COM in Q3 2018?

56 institutional investors reported CASI - CASI PHARMACEUTICALS INC - COM for Q3 2018. Use the holders table for investor-level position and value details.

CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q3 2018 13F Holders as of 30 Sep 2018

Security type / class: Equity / COM
Total 13F shares: 10,748,223
Total 13F value: $50,195,309
Share change: +929,293
SEC-reported price per share: $4.67
Number of holders: 56
Value change: +$4,023,678
Number of buys: 31
Number of sells: 16

Security key

14757U109

Report period

Q3 2018

Institutions

Top holders

CASI full security history Ownership snapshot Full 13F holder table CASI Pharmaceuticals, Inc. SEC filings CASI Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CASI - CASI PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BlackRock Finance, Inc.

Disclosed value leader

BlackRock Finance, Inc.

Comparable rows

0/15

Latest evidence

30 Jun 2018

13F Highest disclosed value: $22,338,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $22.34M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.

Disclosed position value Top 5

BlackRock Finance, Inc. $22.34M

VANGUARD GROUP INC $14.44M

Wellington Shields & Co., LLC $7.83M

Wellington Shields Capital Manage... $7.04M

STATE STREET CORP $4.88M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$22,338,000 2,714,335 shares	—	30 Jun 2018
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$14,441,000 1,754,681 shares	—	30 Jun 2018
Wellington Shields & Co., LLC	13F Company 13F	— denominator unverified	$7,827,000 951,064 shares	—	30 Jun 2018
Wellington Shields Capital Management, LLC	13F Company 13F	— denominator unverified	$7,037,000 855,056 shares	—	30 Jun 2018
STATE STREET CORP	13F Company 13F	— denominator unverified	$4,880,000 593,163 shares	—	30 Jun 2018
NORTHERN TRUST CORP	13F Company 13F	— denominator unverified	$4,654,000 565,458 shares	—	30 Jun 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

10,748,223

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

Q3 2018 holders

Holder diff

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 value	Q3 2018 value	Value change	Value Chg %